2008
DOI: 10.1291/hypres.31.1209
|View full text |Cite
|
Sign up to set email alerts
|

Defective Phosphatidylinositol 3-Kinase Signaling in Central Control of Cardiovascular Effects in the Nucleus Tractus Solitarii of Spontaneously Hypertensive Rats

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
7
0

Year Published

2009
2009
2017
2017

Publication Types

Select...
6
2

Relationship

1
7

Authors

Journals

citations
Cited by 10 publications
(7 citation statements)
references
References 25 publications
0
7
0
Order By: Relevance
“…Indeed, others have shown in other animal models of hypertension that increased levels of PI3K subunits and PI3K activity did not necessarily lead to elevation of PKB/Akt signaling,41 suggesting the presence of a PI3K-dependent but a PKB/Akt-independent signaling pathway. A recent study also revealed that baseline phosphorylated (but not total) PKB/Akt levels are lower in the NTS of SHRs compared with the WKY rats 42. These authors also showed that injection of phosphoinositide(3,4,5)P 3 (a phospholipids second messenger produced by PI3K, thereby mimicking activation of PI3K) in the NTS of the SHR failed to activate the downstream PKB/Akt but produced cardiovascular responses that are in full agreement with the findings of our present study (ie, depressor action).…”
Section: Discussionmentioning
confidence: 92%
“…Indeed, others have shown in other animal models of hypertension that increased levels of PI3K subunits and PI3K activity did not necessarily lead to elevation of PKB/Akt signaling,41 suggesting the presence of a PI3K-dependent but a PKB/Akt-independent signaling pathway. A recent study also revealed that baseline phosphorylated (but not total) PKB/Akt levels are lower in the NTS of SHRs compared with the WKY rats 42. These authors also showed that injection of phosphoinositide(3,4,5)P 3 (a phospholipids second messenger produced by PI3K, thereby mimicking activation of PI3K) in the NTS of the SHR failed to activate the downstream PKB/Akt but produced cardiovascular responses that are in full agreement with the findings of our present study (ie, depressor action).…”
Section: Discussionmentioning
confidence: 92%
“…SHRs are widely used as an animal model to study the pathophysiology and management of hypertension, and a range of abnormalities have been reported in SHRs relative to the normal counterparts, including defection in both Akt-dependent and Akt-independent signaling pathways (Iaccarino et al, 2004 ; Hsiao et al, 2008 ), an increased vasoactive intestinal peptide-mRNA expression (Avidor et al, 1989 ), and a reduced content of vasopressin in the brain (Lang et al, 1981 ), among others, which are supposed to be either a causal or a compensatory factor for the hypertension on SHRs. As to the L-arginine/NO pathway in SHRs, the data varies, which probably depends on the age of the animals.…”
Section: Discussionmentioning
confidence: 99%
“…29 In addition, the defective Akt-eNOS signaling in SHR causes the prehypertensive SHR to develop hypertension. 30 More recently, IGF-1/insulin can modify vascular responses via PI3K/NO pathways in the aorta of WKY rats, but the vascular effects of IGF-1/ insulin in the hypertensive SHRSP may be attenuated due to abnormalities in pathway regulation related to NO bioavailability. 7 Likewise, impaired IGF-1-Akt signaling, which decreases the total amount of PI3K in the heart, occurs at an early age and might contribute to the development of hypertension in SHRSP.…”
Section: Discussionmentioning
confidence: 99%